European Biotech: The Insider View
How has CRISPR changed drug development? How do you negotiate a good partnership? What are…
How has CRISPR changed drug development? How do you negotiate a good partnership? What are…
The US giant Vertex Pharmaceuticals is expanding an existing collaboration with the Swiss company CRISPR…
The biotech industry has often been criticized for its lack of gender diversity. While there…
The gene editing tool CRISPR-Cas9 has revolutionized research in biology. With several parties fighting for…
Abingworth has closed $315M (€268M) for its most recent fund, Abingworth Bioventures VII, which invests in…
In 2016, German pharma giant Bayer took a bold step and decided to partner with…
The FDA has put a hold on CRISPR Therapeutics' planned Phase I/II trial testing a…
Despite all the hype, CRISPR is still not in the clinic as a standalone therapy…
The novel spin given to some traditional and established technologies can be astounding. They might…
CRISPR Therapeutics and Vertex Pharmaceuticals are taking action to start a first clinical trial with…
Over 10,000 human diseases are caused by exactly one faulty gene. Gene therapy promises to fix…
Before the “who to recruit” phase, an important question is “where?” We ran through the…